Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Boehringer Ingelheim Initiates Phase IIa Study of Compound Acquired from Pharmaxis

americanpharmaceuticalreviewAugust 25, 2017

Tag: Boehringer Ingelheim , NAFLD , BI 1467335

PharmaSources Customer Service